252 related articles for article (PubMed ID: 22447293)
1. The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells.
Klein A; Sagi-Assif O; Izraely S; Meshel T; Pasmanik-Chor M; Nahmias C; Couraud PO; Erez N; Hoon DS; Witz IP
Int J Cancer; 2012 Dec; 131(11):2509-18. PubMed ID: 22447293
[TBL] [Abstract][Full Text] [Related]
2. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.
Izraely S; Sagi-Assif O; Klein A; Meshel T; Tsarfaty G; Pasmanik-Chor M; Nahmias C; Couraud PO; Ateh E; Bryant JL; Hoon DS; Witz IP
Int J Cancer; 2012 Sep; 131(5):1071-82. PubMed ID: 22025079
[TBL] [Abstract][Full Text] [Related]
3. CCR4 is a determinant of melanoma brain metastasis.
Klein A; Sagi-Assif O; Meshel T; Telerman A; Izraely S; Ben-Menachem S; Bayry J; Marzese DM; Ohe S; Hoon DSB; Erez N; Witz IP
Oncotarget; 2017 May; 8(19):31079-31091. PubMed ID: 28415693
[TBL] [Abstract][Full Text] [Related]
4. The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells.
Izraely S; Ben-Menachem S; Sagi-Assif O; Telerman A; Zubrilov I; Ashkenazi O; Meshel T; Maman S; Orozco JIJ; Salomon MP; Marzese DM; Pasmanik-Chor M; Pikarski E; Ehrlich M; Hoon DSB; Witz IP
Int J Cancer; 2019 Feb; 144(4):802-817. PubMed ID: 29992556
[TBL] [Abstract][Full Text] [Related]
5. The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis.
Izraely S; Sagi-Assif O; Klein A; Meshel T; Ben-Menachem S; Zaritsky A; Ehrlich M; Prieto VG; Bar-Eli M; Pirker C; Berger W; Nahmias C; Couraud PO; Hoon DS; Witz IP
Int J Cancer; 2015 Mar; 136(6):1296-307. PubMed ID: 25046141
[TBL] [Abstract][Full Text] [Related]
6. The melanoma brain metastatic microenvironment: aldolase C partakes in shaping the malignant phenotype of melanoma cells - a case of inter-tumor heterogeneity.
Izraely S; Ben-Menachem S; Sagi-Assif O; Meshel T; Malka S; Telerman A; Bustos MA; Ramos RI; Pasmanik-Chor M; Hoon DSB; Witz IP
Mol Oncol; 2021 May; 15(5):1376-1390. PubMed ID: 33274599
[TBL] [Abstract][Full Text] [Related]
7. The Challenge of Classifying Metastatic Cell Properties by Molecular Profiling Exemplified with Cutaneous Melanoma Cells and Their Cerebral Metastasis from Patient Derived Mouse Xenografts.
Neuditschko B; Janker L; Niederstaetter L; Brunmair J; Krivanek K; Izraely S; Sagi-Assif O; Meshel T; Keppler BK; Del Favero G; Witz IP; Gerner C
Mol Cell Proteomics; 2020 Mar; 19(3):478-489. PubMed ID: 31892524
[TBL] [Abstract][Full Text] [Related]
8. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
Zubrilov I; Sagi-Assif O; Izraely S; Meshel T; Ben-Menahem S; Ginat R; Pasmanik-Chor M; Nahmias C; Couraud PO; Hoon DS; Witz IP
Cancer Lett; 2015 May; 361(1):86-96. PubMed ID: 25725450
[TBL] [Abstract][Full Text] [Related]
9. Chemokine-chemokine receptor axes in melanoma brain metastasis.
Izraely S; Klein A; Sagi-Assif O; Meshel T; Tsarfaty G; Hoon DS; Witz IP
Immunol Lett; 2010 May; 130(1-2):107-14. PubMed ID: 20005902
[TBL] [Abstract][Full Text] [Related]
10. The metastatic microenvironment: lung-derived factors control the viability of neuroblastoma lung metastasis.
Maman S; Edry-Botzer L; Sagi-Assif O; Meshel T; Yuan W; Lu W; Witz IP
Int J Cancer; 2013 Nov; 133(10):2296-306. PubMed ID: 23649556
[TBL] [Abstract][Full Text] [Related]
11. Chemokines in the melanoma metastasis biomarkers portrait.
Neagu M; Constantin C; Longo C
J Immunoassay Immunochem; 2015; 36(6):559-66. PubMed ID: 25839711
[TBL] [Abstract][Full Text] [Related]
12. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
[TBL] [Abstract][Full Text] [Related]
13. Activation of stat3 in human melanoma promotes brain metastasis.
Xie TX; Huang FJ; Aldape KD; Kang SH; Liu M; Gershenwald JE; Xie K; Sawaya R; Huang S
Cancer Res; 2006 Mar; 66(6):3188-96. PubMed ID: 16540670
[TBL] [Abstract][Full Text] [Related]
14. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
15. Cystatin C takes part in melanoma-microglia cross-talk: possible implications for brain metastasis.
Moshe A; Izraely S; Sagi-Assif O; Prakash R; Telerman A; Meshel T; Carmichael T; Witz IP
Clin Exp Metastasis; 2018 Aug; 35(5-6):369-378. PubMed ID: 29722001
[TBL] [Abstract][Full Text] [Related]
16. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
17. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis.
Zhang RD; Price JE; Schackert G; Itoh K; Fidler IJ
Cancer Res; 1991 Apr; 51(8):2029-35. PubMed ID: 1826230
[TBL] [Abstract][Full Text] [Related]
18. Identification of metastasis-associated genes by transcriptional profiling of a metastasizing versus a non-metastasizing human melanoma cell line.
Brem R; Hildebrandt T; Jarsch M; Van Muijen GN; Weidle UH
Anticancer Res; 2001; 21(3B):1731-40. PubMed ID: 11497253
[TBL] [Abstract][Full Text] [Related]
19. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).
Degen WG; van Kempen LC; Gijzen EG; van Groningen JJ; van Kooyk Y; Bloemers HP; Swart GW
Am J Pathol; 1998 Mar; 152(3):805-13. PubMed ID: 9502422
[TBL] [Abstract][Full Text] [Related]
20. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
